Articles by James Calloway
BAT Shares Surge on FDA Policy Shift and Legal Resolution
British American Tobacco shares rose 5.82% in London after the FDA signaled a softer stance on e-cigarette enforcement and a U.S. judge dismissed a North Korea sanctions case.
Oscar Health Shares Surge as Focus Shifts to Margin Strength
Oscar Health shares rose 7.9% to $23.73 late Tuesday as investors prioritized strong profit margins over a Q1 revenue miss, with the medical loss ratio improving to 70.5%.
Zebra Technologies Surges on Strong Q1 Results and Upgraded Forecast
Shares of Zebra Technologies climbed 11.5% after Q1 earnings beat estimates and the company raised its full-year guidance, pointing to a rebound in automation demand.
UnitedHealth Shares Surge as Investors Bet on Recovery, PBM Reform
UnitedHealth shares climbed 3.1% as the company unveiled a new Optum Rx fee-based pricing model and raised 2026 profit guidance, signaling a potential turnaround.
ZoomInfo Plunges 35% on AI Disruption, Cuts 2026 Revenue Forecast
ZoomInfo shares tumbled 35% Tuesday after the company slashed its 2026 revenue forecast to $1.185-1.205 billion, citing AI-related buying pauses and pricing pressure.
Broadwind Soars 70% as Power-Demand Narrative Overhauls Wind-Tower Exit
Broadwind stock surged ~70% to $3.46 after a smaller-than-expected Q1 loss and revenue beat. Orders jumped 23%, driven by power-generation and natural-gas turbine demand, as the company exits wind-tower production.
3D Systems Soars 28% on Q1 Beat, Healthcare Turnaround Gains Traction
3D Systems stock jumped 28% to $3.22 after Q1 revenue and adjusted EPS beat estimates, with healthcare revenue up 21%.
PACS Group Soars on Upgraded EBITDA Forecast Amid Legal Clouds
PACS Group shares jumped 23% on Q1 results that exceeded expectations, with revenue up 11.2% and net income surging, as the company boosted its 2026 adjusted EBITDA forecast.
